Responsible for driving alignment of brand strategy for advancing access coverage in targeted health systems and payers. As well as, establishing and cultivating productive business relationships within priority remitted accounts. The goal is to advance business priorities included but not limited to new product/indication introduction and launch, product portfolio value proposition (including innovative value strategies and real-world evidence), ensure formulary and pathway product access achievement, and GPO contract pull through. Lead integrated key account planning across commercial partners to help drive a comprehensive business approach to build advocacy and ensure targeted advancement. This includes alignment across all AZ stakeholders, including local customer facing teams, Market access, Marketing, Government Affairs and Medical, to enable optimal coordination of customer engagement so the full value of AZ’s offerings can be realized. Continual evaluation and shaping of accounts to be in line with access strategy, payer goals and review of current contracts to consider alternative agreements.

Institutional Account Manager-(Liver/Gastroenterology/Hepatology) May 2017- June 2021Area Field Trainer-Central RegionAs an Institutional Account Manager, I am responsible for representing Salix’s portfolio of business relative to Liver and Gastroenterology disease state which includes the states of Tennessee, Alabama, Mississippi, and Georgia within all my target accounts.Tasked with calling on Suite C and D customers to implement a comprehensive approach to treat patients suffering with hepatic encephalopathy through the implementation of a meds to beds program. This is a complex strategy that incorporates many stakeholders. (pharmacy, head of hepatology, director of gastroenterology, informatic pharmacist, PNT, etc.)Responsible for disseminating pharmacoeconomic data to my target list of accounts, which include hospitals, specialty pharmacies, and select IDN’s within my geography. I am also tasked with educating medical school and pharmacy school residents relative to disease state information, product information, and formulary coverage.As part of a dedicated team of leaders, I am accountable for creating and maintaining access to all Salix portfolio of products within my Key Accounts. Establish deep relationships with payers and health systems to create access across formularies, define treatment algorithms and apply these within the systems EMR platform to better treat patients through population management protocols.

As a Cardiovascular Account Specialist I was responsible for representing Lilly as an industry Cardiovascular disease, market, and product specialist with key hospitals and office based cardiology practices. This is a complex selling environment requiring proactive management of key clinical, quality and economic influencers. The strategic intent of the CAS role is to maximize territory sales of Lilly products in the hospital and retail setting by managing patient, product, and dollar flow for ACS-PCI and insulin markets in the territory. CAS representatives are responsible for coordinating with appropriate diabetes overlaps for the outpatient insulin market. Proactively monitor competitive strategies and effectively position Lilly products and services for appropriate patients. Build clinical champions and align our solutions to hospital goals. Role model deep clinical expertise. Demonstrate effective analysis and decision making skills. Demonstrate effective and organizational skills. Manage and implement plans by allocating appropriate resources in the form of time, materials, and programs.

Please refer to above description.

Tennessee Account Director for Public Payer -Accountable for contracting for the entire Lilly portfolio with Tennessee Medicaid, working with the management team across the state of Tennessee. Local market expert regarding coverage and payer access. Work closely with state government affairs as well as executive partnership with Lilly executives to put together a strategic account management initiative for the state. Responsible for a comprehensive local market strategic plan that includes working with top formulary decision makers that includes, PNT members, First Health-PBM customers, TennCare representatives and local market advocates. Additional responsibility was to inform key stakeholders of access and formulary availability that included CMHC's, State Institutions, and large managed care formularies (Blue Cross Blue Shield).

Responsible for Lilly's neuroscience portfolio which includes an antipsychotic, antidepressant, and ADHD medication. Worked in Long Term Care, VA, DOD, and Institutional setting working closely with staff, nurses, and physicians to provide them with evidence based medicine through deep clinical knowledge while effectively promoting patient care. Developed deep clinical knowledge and market knowledge in regard to Long Term Care through interactions working with Directors of Nursing, Nurses, Nurse Practitioners, Psychiatrists, and Physicians. Have worked with AIM testing to help identify patients that suffer from movement disorders. Additional responsibilities included targeted speaker programs, ensuring formulary access (VA and DOD), and disease state education to UT Medical school residents. Promoted and successfully launched Cymbalta for Depression and Pain indications. Promoted and successfully launched Zyprexa IM (acute injectable) in the acute setting which included, state institutions as well as hospital ER's in my geographic region.

As a psychiatry specialty district manager for Wyeth, my responsibility was to lead, coach and inspire a team of 8 psychiatry specialty representatives in the West and Middle Tennessee market. Skillful account planning leader able to collaborate with key stakeholders and coordinate action plans to maximize market share increase to exceed goals through patient advocacy by demonstrating excellence in clinical confidence and persuasive selling. Consistently lead my teams to deliver outstanding results through strong leadership and effective coaching. Top district in Tennessee in 2002. Circle of excellence too 10%, division final end year rank 2002- #2. Selected by leadership for STAR- future director candidate pool.

As a specialty representative for Wyeth, my responsibilities included the marketing of Effexor XR (antidepressant) and Sonata (Sleeper). Core requirements were to market the neuroscience portfolio in psychiatry based offices, CMHC's, and targeted hospitals. Build key thought leaders through speaker development, utilize key speakers to establish overall market penetration with local and regional sales representatives, primary responsibility was to ensure proper training of speakers, which included personally escorting physcians to speaker education seminars, and having proper utilization of speakers throughout the country. Conducted or was involved in over 300 speaker programs. Was also designated as Area Field Trainer, which involved working with other colleagues in the area to ensure proper onboarding of new representatives, ensure deep product and disease state knowledge while understanding the payer landscape.